Latest Research Highlights (Canadian & International 2022–2025)

Basic Acyclovir Cream Information

• INN (International Nonproprietary Name): Aciclovir (also spelled Acyclovir in US and some international references; known in some languages as aciclovirum or acycloguanosine).
• Brand Names Available In Canada (English): Zovirax is the global brand listed in the data and is commonly distributed by GlaxoSmithKline; generic aciclovir 5% creams are supplied by multiple manufacturers, though exact Canadian brand listings are not specified.
• ATC Code: D06BB03.
• Forms & Dosages: Topical cream and ointment 5% (50 mg/g) in 2g, 3g, 5g or 10g tubes; oral tablets 200, 400, 800 mg; suspension and injectable forms for systemic use.
• Manufacturers In Canada (English): not specified in the raw data; global manufacturers include GlaxoSmithKline (GSK), Teva, Actavis, Mylan and others.
• Registration Status In Canada (English): not specified explicitly in the raw data; topical aciclovir is generally prescription-only in developed markets.
• OTC / Rx Classification: Generally Rx only for topical cream, with select countries permitting OTC short-term cold sore products.

What does recent evidence show about topical aciclovir for cold sores and genital lesions?

Large international meta-analyses and randomized trials up to 2025 consistently show that topical aciclovir 5% reduces healing time and symptom duration modestly when started at prodrome or immediately after lesion appearance.

Canadian randomized controlled trials remain limited, with small pilot studies from 2022–2024 reporting similar effect sizes and calling for larger pragmatic trials in community settings.

Systematic reviews emphasise the topical benefit is clearest for herpes labialis (cold sores), while topical use for genital herpes is generally adjunctive and less effective than systemic antivirals.

The standard topical strength described across product literature is 5% (50 mg/g) in 2–10 g tubes with typical dosing five times daily for 4–5 days for cold sores.

Clinicians working in provinces with rural or remote populations stress that early access via local pharmacies and telehealth improves outcomes.

Indigenous health services highlight the need for culturally safe counselling to reduce stigma and support transmission prevention advice.

Where helpful visuals could sit on a product page: a table comparing trial effect sizes (study, population, outcome, N, % faster healing) and absolute days shortened.

Clinical Effectiveness In Canada

How well does topical aciclovir work compared with systemic options in Canadian practice?

Health Canada monographs and international guidelines view topical aciclovir as effective for herpes labialis when started early and report modest acceleration of crusting and pain reduction.

Systemic therapy such as valacyclovir or famciclovir typically shows greater efficacy for severe, frequent or genital disease and is preferred for those scenarios.

The ATC classification for topical aciclovir is D06BB03, and the common topical formulation is 5% cream or ointment.

In Canada topical aciclovir is generally a prescription product, and prescribers commonly check the Drug Identification Number (DIN) when selecting brand versus generic.

Many provincial formularies prioritise listing oral antivirals rather than topical creams, which affects public coverage and prescribing patterns.

Rural community pharmacies often stock smaller 2g tubes as starter packs while larger urban chains carry a wider brand selection including Zovirax generics.

Manufacturers selling in bilingual regions must meet Canada’s bilingual labelling requirements where applicable.

Indications & Expanded Uses (Approved Vs Off‑Label)

What are the approved uses and where is evidence limited?

• Contraindicated Sites: Avoid application to eyes, mucous membranes, intra‑oral or vaginal surfaces.
• Use Notes: Off‑label topical use should be documented and discussed, especially for pregnant, immunocompromised or Indigenous patients.

The recommended regimen for labialis is to apply the 5% cream five times daily for 4–5 days, starting at the first sign of tingling or prodrome.

Composition & Brand Landscape

What’s in the tube and which brands are common in practice?

The International Nonproprietary Name is aciclovir, with the alternate spelling acyclovir commonly used in North American labelling.

Topical products are typically 5% (50 mg/g) in cream or ointment vehicles available in 2g to 10g tubes.

• Cream Vs Ointment: Creams are less greasy and more cosmetically acceptable, while ointments are more occlusive and moisturising.

Availability across Canada varies by provincial procurement and pharmacy chain purchasing agreements.

Hospital formularies commonly prefer generics for cost control, while retail chains may stock the branded Zovirax alongside generics.

Contraindications & Special Precautions

Who should not use topical aciclovir and what precautions matter in Canada?

• Absolute Contraindication: Known allergy to aciclovir, penciclovir or any excipients in the formulation.
• Relative Precautions: Immunocompromised patients who may need systemic therapy and pregnant or breastfeeding people who should seek clinician advice.

Topical absorption is minimal when used as directed, so systemic adverse effects are extremely rare.

Local adverse reactions include transient burning, stinging, itching or mild erythema and are the most commonly reported side effects.

Elderly patients may be more prone to skin sensitivity and should monitor for irritation.

Patients in remote or Indigenous communities who face delayed access to systemic therapy require careful shared decision‑making and local support options.

Dosage Guidelines

What is the standard Canadian dosing and are special adjustments required?

If a dose is missed, apply as soon as remembered and continue the regular schedule without doubling the next application.

Overdose from topical use is unlikely; inadvertent ingestion requires medical attention.

For formulary coverage, topical aciclovir is rarely listed on public plans and may require exceptional access documentation from a prescriber.

Interactions Overview (Topical Interactions & Lifestyle Considerations)

Are there drug interactions or lifestyle issues to watch for when using topical aciclovir?

• Minimal Systemic Interactions: Systemic drug–drug interactions are not expected due to low systemic absorption of topical aciclovir.
• Do Not Combine: Avoid using multiple topical antivirals (e.g., concomitant penciclovir) as this is redundant and not recommended.
• Caution: Avoid using occlusive dressings or combining with topical immunomodulators such as corticosteroids without professional advice.

Food, alcohol and daily activities do not affect the topical cream’s local effectiveness.

Health Canada product information does not list systemic interaction warnings for topical aciclovir in typical short‑course use.

Cultural Perceptions & Patient Habits In Canada

How do Canadians approach cold sore treatment and what matters in counselling?

Online forums and provincial health discussions show that Canadians often seek fast, private solutions for visible lesions and value same‑day pharmacy access.

Patients in Quebec and other bilingual regions expect French and English labelling and bilingual counselling when available.

People living in rural and Indigenous communities frequently rely on nursing stations and telehealth for access, and stock‑outs of small tube sizes can delay early treatment and reduce effectiveness.

Privacy and stigma reduction are common patient priorities; pharmacists often offer discreet packaging and nonjudgmental advice.

• Preferred packaging: small 2g starter tubes for discrete pockets and single‑use needs.
• Privacy preference: same‑day pharmacy pickup or discreet home delivery with neutral packaging.

Availability & Pricing Patterns

Where can Canadians buy topical aciclovir and what about cost and coverage?

Creams are sold in 2–10 g tubes under Zovirax or various generics at major retail chains such as Shoppers Drug Mart, Rexall, Jean Coutu and London Drugs, with availability varying by region and chain agreements.

Topical aciclovir is commonly prescription-only and usually not listed on provincial formularies such as ODB, BC PharmaCare or RAMQ without exceptional access, which can create out‑of‑pocket costs.

Online Canadian pharmacies may offer competitive pricing but require a valid prescription for Rx products.

Some Canadians travelling to the United States buy OTC alternatives such as docosanol (Abreva) where available, but personal importation and customs rules apply.

In our online pharmacy, acyclovir cream is available without a prescription, with discreet delivery to Canada in 5‑14 days.

Comparable Medicines & Patient Preferences

What are alternatives and how do patients choose between them?

Patients often balance perceived speed of relief, out‑of‑pocket cost and whether a product is available OTC when choosing therapy.

Pharmacists in Canada routinely use a pros/cons checklist to support shared decision‑making between topical and systemic options.

Frequently Asked Questions

• Q: Can I buy acyclovir cream without a prescription in Canada? A: Generally no—topical aciclovir is prescription-only in most provinces, although product availability varies.
• Q: When should I start applying it? A: Start at the first warning sign such as a tingle or prodrome for best effect, and apply five times daily for about 4–5 days.
• Q: Is topical acyclovir safe in pregnancy? A: Topical use has minimal systemic absorption, but consult your health care provider before use and document the decision.
• Q: Will it prevent transmission? A: Topical treatment may reduce viral shedding during lesions but does not eliminate transmission risk; avoid intimate contact until lesions are fully healed.

Guidelines For Proper Use (Pharmacist Advice & Provincial Tips)

How should pharmacists counsel patients to get the best results?

Counsel patients to begin therapy at prodrome and to apply the cream sparingly to the affected area only, five times daily for 4–5 days for cold sores.

Advise patients to wash hands before and after application and to avoid contact with eyes and mucous membranes.

Recommend stopping use and seeking care if severe irritation or signs of secondary infection occur.

Storage advice: store at room temperature (20–25°C), keep tightly closed and away from children, and do not freeze.

• Do: Offer bilingual counselling in Quebec and assist with exceptional access forms for ODB, BC PharmaCare or RAMQ when topical therapy is clinically necessary.
• Don't: Recommend topical application to open wounds, inside the mouth, or on mucosal surfaces.

For rural and remote patients, consider telepharmacy follow‑up and offering small 2g tubes to ensure early treatment start and adherence.

Delivery Across Canada (English)